173 related articles for article (PubMed ID: 19822838)
1. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.
Ho GY; Xue X; Cushman M; McKeown-Eyssen G; Sandler RS; Ahnen DJ; Barry EL; Saibil F; Bresalier RS; Rohan TE; Baron JA
J Natl Cancer Inst; 2009 Dec; 101(23):1650-4. PubMed ID: 19822838
[TBL] [Abstract][Full Text] [Related]
2. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
Cole BF; Baron JA; Sandler RS; Haile RW; Ahnen DJ; Bresalier RS; McKeown-Eyssen G; Summers RW; Rothstein RI; Burke CA; Snover DC; Church TR; Allen JI; Robertson DJ; Beck GJ; Bond JH; Byers T; Mandel JS; Mott LA; Pearson LH; Barry EL; Rees JR; Marcon N; Saibil F; Ueland PM; Greenberg ER;
JAMA; 2007 Jun; 297(21):2351-9. PubMed ID: 17551129
[TBL] [Abstract][Full Text] [Related]
3. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas.
Passarelli MN; Barry EL; Zhang D; Gangar P; Rees JR; Bresalier RS; McKeown-Eyssen G; Karagas MR; Baron JA
Br J Dermatol; 2018 Aug; 179(2):337-344. PubMed ID: 29570772
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial.
Passarelli MN; Barry EL; Rees JR; Mott LA; Zhang D; Ahnen DJ; Bresalier RS; Haile RW; McKeown-Eyssen G; Snover DC; Cole BF; Baron JA
Am J Clin Nutr; 2019 Oct; 110(4):903-911. PubMed ID: 31401653
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
6. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.
Figueiredo JC; Levine AJ; Grau MV; Barry EL; Ueland PM; Ahnen DJ; Byers T; Bresalier RS; Summers RW; Bond J; McKeown-Eyssen GE; Sandler RS; Haile RW; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2625-31. PubMed ID: 18843003
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
8. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.
Figueiredo JC; Levine AJ; Grau MV; Midttun O; Ueland PM; Ahnen DJ; Barry EL; Tsang S; Munroe D; Ali I; Haile RW; Sandler RS; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2136-45. PubMed ID: 18708408
[TBL] [Abstract][Full Text] [Related]
9. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
Cole BF; Logan RF; Halabi S; Benamouzig R; Sandler RS; Grainge MJ; Chaussade S; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):256-66. PubMed ID: 19211452
[TBL] [Abstract][Full Text] [Related]
10. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
[TBL] [Abstract][Full Text] [Related]
11. Folic acid and risk of prostate cancer: results from a randomized clinical trial.
Figueiredo JC; Grau MV; Haile RW; Sandler RS; Summers RW; Bresalier RS; Burke CA; McKeown-Eyssen GE; Baron JA
J Natl Cancer Inst; 2009 Mar; 101(6):432-5. PubMed ID: 19276452
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.
Wu K; Platz EA; Willett WC; Fuchs CS; Selhub J; Rosner BA; Hunter DJ; Giovannucci E
Am J Clin Nutr; 2009 Dec; 90(6):1623-31. PubMed ID: 19864409
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis.
Zhang X; Liu S; Zhou Y
Oncotarget; 2016 Sep; 7(39):64371-64379. PubMed ID: 27608842
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.
Chan AT; Ogino S; Giovannucci EL; Fuchs CS
Gastroenterology; 2011 Mar; 140(3):799-808, quiz e11. PubMed ID: 21115010
[TBL] [Abstract][Full Text] [Related]
16. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
[TBL] [Abstract][Full Text] [Related]
17. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
[TBL] [Abstract][Full Text] [Related]
20. Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.
Passarelli MN; Barry EL; Rees JR; Mott LA; Ahnen DJ; Baron JA
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1262-1265. PubMed ID: 31263057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
